Overview

Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare the uptake of azithromycin in white cells relative to plasma concentrations in HIV-infected patients.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Azithromycin